PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRFX PRF Technologies Ltd.

Closed Memorial Day 05-22 16:00:00 EDT

1.49

+0.04

+2.76%

盘后1.42

-0.07-4.70%

19:30 EDT

High1.53	Low1.34	Vol114.42K
Open1.37	D1 Closing1.45	Amplitude13.10%
Mkt Cap1.29M	Tradable Cap1.21M	Total Shares868.80K
T/O162.45K	T/O Rate14.15%	Tradable Shares808.80K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRFX","market":"US","secType":"STK","nameCN":"PRF Technologies Ltd.","latestPrice":1.49,"timestamp":1779480000000,"preClose":1.45,"halted":0,"volume":114415,"hourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.49,"latestTime":"19:30 EDT","volume":6364,"amount":9032.1552,"timestamp":1779492649561,"change":-0.07,"changeRate":-0.04698,"amplitude":0.060403},"delay":0,"changeRate":0.027586206896551748,"floatShares":808800,"shares":868800,"eps":-7.469999,"marketStatus":"Closed Memorial Day","change":0.04,"latestTime":"05-22 16:00:00 EDT","open":1.37,"high":1.53,"low":1.34,"amount":162449.963865,"amplitude":0.131034,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-7.469999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"listingDate":1598932800000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.36,"preClose":1.45,"latestTime":"09:29 EDT","volume":14351,"amount":19129.9662358,"timestamp":1779456586672,"change":-0.09,"changeRate":-0.062069,"amplitude":0.034483},"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.49,"latestTime":"19:30 EDT","volume":6364,"amount":9032.1552,"timestamp":1779492649561,"change":-0.07,"changeRate":-0.04698,"amplitude":0.060403},"volumeRatio":0.15612599573773417},"requestUrl":"/m/hq/s/PRFX/wiki","defaultTab":"wiki","newsList":[{"id":"2633033431","title":"PRF Technologies sells 24,384 unregistered shares to Yorkville for fees","url":"https://stock-news.laohu8.com/highlight/detail?id=2633033431","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633033431?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:10","pubTimestamp":1778191839,"startTime":"0","endTime":"0","summary":"PRF Technologies entered standby equity purchase agreement with Yorkville that allows sales of up to USD 10 million of ordinary shares over 36 months in an unregistered offering under Section 4 and Rule 506 of Regulation D.Advance shares would be sold at 97% of lowest of three daily VWAPs over a three-trading-day pricing period, with option to set a minimum price.Upfront equity fees issued on signing included 12,192 ordinary shares as first installment of 1% commitment fee, another 12,192 ordinary shares for a USD 25,000 structuring fee.Future advances require SEC registration statement covering commitment, structuring, and advance shares to be declared effective.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. pub","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL6tR973:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630300371","title":"PRF Technologies announces FDA clearance of OcuRing-K NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2630300371","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630300371?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:13","pubTimestamp":1777382015,"startTime":"0","endTime":"0","summary":"PRF Technologies (PRFX) announced that the FDA has cleared the company’s investigational new drug application for OcuRing-K, enabling the initiatio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prf-technologies-announces-fda-clearance-of-ocuring-k-nda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prf-technologies-announces-fda-clearance-of-ocuring-k-nda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRF","LABU","BK4588","BK4007","BK4585","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630301770","title":"PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630301770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630301770?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:15","pubTimestamp":1777378541,"startTime":"0","endTime":"0","summary":"PRF Technologies received FDA clearance for IND application for OcuRing-K, enabling Phase II trial in cataract surgery patients.Multi-center US study start-up underway, with enrollment expected to begin in H2 2026.OcuRing-K is sustained-release intraocular ring delivering ketorolac via single intraoperative application.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL5n3lSg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SG9999014013.SGD","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2W23.USD","BK4588","LU2210149790.SGD","BK4007","PRFX","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4112","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4585","NDAQ","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630309729","title":"Prf Technologies Ltd - to Initiate Phase Ii Trial in U.S. With Enrollment Expected in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630309729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630309729?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:00","pubTimestamp":1777377606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUA55N0XD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630097283","title":"Prf Technologies Announces FDA Clearance of Ind Application for Ocuring™-K Phase Ii Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630097283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630097283?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:00","pubTimestamp":1777377606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUA55N0XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625951259","title":"What's Going On With Pharma Company PRF Technologies On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625951259","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625951259?lang=en_us&edition=fundamental","pubTime":"2026-04-07 23:02","pubTimestamp":1775574132,"startTime":"0","endTime":"0","summary":"PRF Technologies outlines 2025 progress, with OcuRing-K ocular drug-delivery advancement and AI solar analytics growth.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/small-cap/26/04/51682881/whats-going-on-with-pharma-company-prf-technologies-on-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRF","BK4588","SMA","BK4585","BK4007","BK4217","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625467666","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2625467666","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625467666?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:17","pubTimestamp":1775474273,"startTime":"0","endTime":"0","summary":"PRF Technologies  shares were 40% higher pre-bell Monday following a largely muted previous session.Soleno Therapeutics  stock was up 39% after the company agreed to be acquired by Neurocrine Biosciences  in a $2.9 billion deal.Gilat Satellite Networks  shares were 4.4% higher, adding to gains from the previous session.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065170008.USD","BK4020","SLNO","BK4139","LU0109394709.USD","LU2065171311.SGD","IE00B66KJ199.SGD","PRFX","IE00B19Z4B17.USD","LU2065169927.USD","BK4007","LU0320765992.SGD","IE0031619046.USD","IE00B7SZL793.SGD","LU0154245756.USD","NBIX","GILT","LU0154245673.USD","LU2065171402.SGD","LU0889565916.HKD","LU2324357040.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826067","title":"Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826067?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:09","pubTimestamp":1774613359,"startTime":"0","endTime":"0","summary":"Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expensesOverviewIsrael healthcare and energy tech firm's 2025 net loss narrowed sharply from prior yearCompany completed De","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL1N40F0DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622782826","title":"PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M","url":"https://stock-news.laohu8.com/highlight/detail?id=2622782826","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622782826?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:05","pubTimestamp":1774613123,"startTime":"0","endTime":"0","summary":"LayerBio&#39;s OcuRing™-K program and broader ocular platform strengthen PRF&#39;s healthcare growth strategyDeepSolar advances from acquisition to early commercial deployment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51504675/prf-technologies-in-fy25-had-4-1m-in-cash-cash-equivalents-short-term-deposits-and-restricted-cash-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","PRF","BK4550","BK4007","BK4585","VHT","BK4588","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622982697","title":"Prf Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=2622982697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622982697?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nTUA8JV2VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826971","title":"PainReform Ltd FY Net Income USD -4.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826971?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nPLXAFB761:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622948891","title":"PRF Technologies FY2025 operating loss narrows 65.1% to $5.1 million; revenue falls to $17,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2622948891","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622948891?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:07","pubTimestamp":1774559230,"startTime":"0","endTime":"0","summary":"PRF Technologies published an annual report on Form 20-F for the fiscal year ended Dec. 31, 2025.Revenue was USD 17,000, while net loss attributable to shareholders was USD 4.8 million.Research and development expense fell 90.6% to USD 1.1 million, primarily due to extensive clinical trial costs in 2024, partly offset by additional R&D tied to LayerBio activities.Cash and cash equivalents  were USD 4.1 million as of Dec. 31, 2025, and management said there is substantial doubt about the company’s ability to continue as a going concern.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syst","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3GLZHk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620626293","title":"PRF Technologies Ltd. files Form 3 for COO Aviel Sigal","url":"https://stock-news.laohu8.com/highlight/detail?id=2620626293","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620626293?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:15","pubTimestamp":1773872139,"startTime":"0","endTime":"0","summary":"PRF Technologies reported an initial statement of beneficial ownership by Aviel Sigal, its chief operating officer. Sigal reported employee stock options covering 3,759 ordinary shares. The reported exercise prices were USD 15.75 and USD 684.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8SX9VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620935082","title":"PRF Technologies Director Ellen S. Baron Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620935082","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620935082?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:12","pubTimestamp":1773871953,"startTime":"0","endTime":"0","summary":"PRF Technologies reported an initial statement of beneficial ownership by director Ellen Baron. The filing listed employee stock options for 50 ordinary shares at an exercise price of USD 5,400. It also listed employee stock options for 183 ordinary shares at an exercise price of USD 30.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLZN9Bb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620429354","title":"PRF Technologies files initial beneficial ownership statement for Interim CEO Efraim Cohen-Arazi","url":"https://stock-news.laohu8.com/highlight/detail?id=2620429354","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620429354?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:10","pubTimestamp":1773871821,"startTime":"0","endTime":"0","summary":"PRF Technologies reported that Efraim Cohen-Arazi filed an initial statement of beneficial ownership as a director. The filing also lists Cohen-Arazi as an officer with the title Interim CEO. Cohen-Arazi reported employee stock options covering 3,383 ordinary shares. The options include exercise prices of USD 5,400 and USD 706.8.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1JkFHx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620933492","title":"PRF Technologies Ltd. files Form 3 for Executive Chairman Ehud Geller","url":"https://stock-news.laohu8.com/highlight/detail?id=2620933492","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620933492?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:07","pubTimestamp":1773871622,"startTime":"0","endTime":"0","summary":"PRF Technologies filed an initial statement of beneficial ownership reporting Ehud Geller as a director and executive chairman of the board. The filing reported employee stock options covering 20,314 ordinary shares with an exercise price of USD 0.05. It also reported employee stock options covering 1,219 ordinary shares with an exercise price of USD 30.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6sqPqj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620293857","title":"PRF Technologies Ltd. files initial beneficial ownership statement for CFO Eyal Broder","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293857","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620293857?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:01","pubTimestamp":1773871311,"startTime":"0","endTime":"0","summary":"PRF Technologies reported an initial statement of beneficial ownership by Eyal Broder, its chief financial officer. The filing listed employee stock options covering 180 ordinary shares with an exercise price of USD 30. It also reported employee stock options covering 2,000 ordinary shares with an exercise price of USD 15.75.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL2CtJdK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620298729","title":"PRF Technologies Director Augustine Lawlor Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620298729","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620298729?lang=en_us&edition=fundamental","pubTime":"2026-03-19 05:57","pubTimestamp":1773871059,"startTime":"0","endTime":"0","summary":"Augustine Lawlor filed an initial statement of beneficial ownership for PRF Technologies in his role as a director. Lawlor reported employee stock options to buy 50 ordinary shares at an exercise price of USD 5,400. He also reported employee stock options to buy 183 ordinary shares at an exercise price of USD 30.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL123xwC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620129820","title":"PRF Technologies Ltd. director Shavit Asaf files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620129820","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620129820?lang=en_us&edition=fundamental","pubTime":"2026-03-19 05:54","pubTimestamp":1773870871,"startTime":"0","endTime":"0","summary":"PRF Technologies reported an initial statement of beneficial ownership by director Asaf Shavit. Shavit reported beneficial ownership of employee stock options covering 3,000 ordinary shares. The options have an exercise price of USD 5.55 and an expiration date of Nov. 24, 2035.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL2RVjP3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620422585","title":"BRIEF-Prf Technologies Ltd. Announces Commercial Collaboration Agreement With Blade Ranger To Accelerate Large-Scale Deepsolar Commercial Engagements","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422585","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422585?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:36","pubTimestamp":1773750965,"startTime":"0","endTime":"0","summary":"BRIEF-Prf Technologies Ltd. Announces Commercial Collaboration Agreement With Blade Ranger To Accelerate Large-Scale Deepsolar Commercial EngagementsMarch 17 (Reuters) - PRF Technologies Ltd PRFX.O:PR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA6S5F8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prf-tech.com","stockEarnings":[{"period":"1week","weight":-0.057},{"period":"1month","weight":-0.4016},{"period":"3month","weight":-0.5694},{"period":"6month","weight":-0.6555},{"period":"1year","weight":-0.8472},{"period":"ytd","weight":-0.5357}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.0371},{"month":2,"riseRate":0.5,"avgChangeRate":0.071344},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.110271},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.187964},{"month":5,"riseRate":0,"avgChangeRate":-0.156698},{"month":6,"riseRate":0.4,"avgChangeRate":-0.0782},{"month":7,"riseRate":0.4,"avgChangeRate":-0.022654},{"month":8,"riseRate":0.4,"avgChangeRate":-0.15911},{"month":9,"riseRate":0.2,"avgChangeRate":-0.17317},{"month":10,"riseRate":0,"avgChangeRate":-0.160968},{"month":11,"riseRate":0.5,"avgChangeRate":-0.020834},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071991}],"exchange":"NASDAQ","name":"PRF Technologies Ltd.","nameEN":"PRF Technologies Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PRF Technologies Ltd.(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PRF Technologies Ltd.,PRFX,PRF Technologies Ltd.股票,PRF Technologies Ltd.股票老虎,PRF Technologies Ltd.股票老虎国际,PRF Technologies Ltd.行情,PRF Technologies Ltd.股票行情,PRF Technologies Ltd.股价,PRF Technologies Ltd.股市,PRF Technologies Ltd.股票价格,PRF Technologies Ltd.股票交易,PRF Technologies Ltd.股票购买,PRF Technologies Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PRF Technologies Ltd.(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction